Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
27.0%
% of XLV's 64 holdings also in FTXH
34.0%
% of FTXH's 51 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in FTXH |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 6.8% | 6.9% | 6.8% | |
MERCK & CO. INC. | 6.2% | 7.6% | 6.2% | |
ABBVIE INC | 5.3% | 6.8% | 5.3% | |
ELI LILLY & CO | 11.4% | 3.7% | 3.7% | |
AMGEN INC | 3.1% | 4.2% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FTXH
UNITEDHEALTH GROUP INC | 8.9% | |
ELI LILLY & CO | 7.7% | |
THERMO FISHER SCIENTIFIC INC | 4.3% | |
ABBOTT LABORATORIES | 3.4% | |
DANAHER CORP | 3.1% | |
INTUITIVE SURGICAL INC | 2.6% | |
ELEVANCE HEALTH INC | 2.4% | |
STRYKER CORP | 2.1% | |
MEDTRONIC PLC | 2.1% | |
BOSTON SCIENTIFIC CORP | 2.0% |
XLV Underweight Relative to FTXH
BRISTOL-MYERS SQUIBB CO | -4.8% | |
PFIZER INC | -4.8% | |
UNITED THERAPEUTICS CORP | -3.9% | |
BIOGEN IDEC INC | -3.2% | |
VIATRIS, INC. | -3.1% | |
JAZZ PHARMACEUTICALS PLC | -3.0% | |
ORGANON & CO. | -3.0% | |
CARDINAL HEALTH INC | -2.8% | |
GILEAD SCIENCES INC | -1.8% | |
REGENERON PHARMACEUTICALS | -1.8% |